Preferred Label : dextroamphetamine;

MeSH definition : The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.;

MeSH synonym : dexamfetamine; d amphetamine; d-amphetamine; dexamphetamine; dextro amphetamine; dextro-amphetamine;

CISMeF synonym : GlaxoSmithKline brand of dextroamphetamine sulfate; celltech brand of dextroamphetamine sulfate; mallinckrodt brand of dextroamphetamine sulfate; pasadena brand of dextroamphetamine; shire brand of dextroamphetamine sulfate; vortech brand of dextroamphetamine sulfate;

MeSH hyponym : oxydess; DextroStat; dextroamphetamine sulfate; curban; dexedrine; Sulfate, Dextroamphetamine; Dextro-Amphetamine Sulfate; Dextro Amphetamine Sulfate; d-Amphetamine Sulfate; d Amphetamine Sulfate;

MeSH CAS label : benzeneethanamine, alpha-methyl-, (S)-;

MeSH Related Number : 51-64-9 (Dextroamphetamine); dextroamphetamine sulfate; JJ768O327N;

Registry Number MeSH : 51-64-9;

Related CAS MeSH : JJ768O327N (Dextroamphetamine sulfate);

Wikipedia link : https://en.wikipedia.org/wiki/Dextroamphetamine;

Codes EINECS : 200-112-1;

Is substance : O;

UNII : TZ47U051FI;

InChIKey : KWTSXDURSIMDCE-QMMMGPOBSA-N;

Details


Main resources

You can consult :

The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.

https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portraits-decrivant-les-interventions-pharmacologiques-et-non-pharmacologiques-entourant-le-trouble-du-deficit-de-lattention-avec-ou-sans-hyperactivite-tdah-chez-les-quebecois-de-25-ans-et-moins.html
2017
false
false
false
Canada
French
practice guideline
attention deficit disorder with hyperactivity
child
adolescent
young adult
quebec
review of literature
central nervous system stimulants
methylphenidate
dextroamphetamine
Delayed-Action preparations
Lisdexamfetamine Dimesylate
Atomoxetine Hydrochloride
centrally acting sympathomimetics
age factors
sex factors
drug utilization
drug utilization

---
Nous contacter.
25/02/2026


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.